Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America. - Wikidata - awgldk - TriplyDB

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

http://www.wikidata.org/entity/Q34149992

about

Small cell lung cancer (SCLC): no treatment advances in recent years Nomogram prediction for the survival of the patients with small cell lung cancer.Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients.Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer.Lung cancer stigma, depression, and quality of life among ever and never smokers Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells Effect of cigarette smoking on quality of life in small cell lung cancer patients Lung cancer stigma, anxiety, depression, and quality of life.Lung cancer: Biology and treatment options.Targeted therapies in small-cell lung cancer.Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study.Vasculogenic mimicry in small cell lung cancer.Effects of chemotherapy on survival of elderly patients with small-cell lung cancer: analysis of the SEER-medicare database.Cancer stem cells in lung cancer: Evidence and controversies.Update on new drugs in small cell lung cancer.Notch signaling in lung cancer.Novel strategies for the treatment of small-cell lung carcinoma.The role of radiation therapy in small cell lung cancer.Lung cancer stem cells and implications for future therapeutics.Microtubule-associated protein 1B: Novel paraneoplastic biomarker.Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.Combination of HDAC and topoisomerase inhibitors in small cell lung cancer.Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.Surgical treatment of early stage small cell lung cancer.Frequency of O⁶-methylguanine-DNA methyltransferase promoter methylation in cytological samples from small cell lung cancer.Optimization of small-cell lung cancer chemotherapy with heparin: a comprehensive retrospective study of 239 patients treated in a single specialized center.Changing epidemiology of elderly small cell lung cancer patients over the last 40 years; a SEER database analysis.Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy.Immune checkpoint inhibitors in small cell lung cancer.

P2860

Q26767020-2B07BB90-5397-416A-A5C2-212BB810A217 Q33571276-BDD69468-1415-441E-B3BD-C2D67F10C04A Q33625372-7E1EFC48-EB5D-4C4A-A89D-3BCEB5EAC16D Q33817153-3681B04C-602A-402B-BA95-EE2800B8C381 Q34994818-431B9CBB-8795-4605-9D9E-0CC3AB2F14D3 Q35789345-F84E1515-CBBF-46FD-8A7B-7A8555C50E5A Q35989582-90EB83F8-C9AA-420E-8215-2438B0529EFC Q36014432-E3834905-A4AB-4371-B3DF-53BD816EC5C8 Q36116072-E1F1F23C-C013-4EC7-AFA1-7D97EE7629C9 Q36252711-0E6A2C56-8342-4F9F-87DC-E4DC463D306C Q36328370-87AC4C2D-A099-4EFA-B228-77B04081743D Q36897340-44B3EE7D-9028-45EF-9D1D-62A5295140E8 Q37283557-97107ED0-2442-4896-8B9E-6A5452302790 Q37408684-6322916D-B5D0-4A34-A6D3-A59C26088E07 Q37515251-BC3BCEA7-8C58-4126-84C6-E12B31B8B949 Q37709551-EAD14BD1-D3A0-40D2-B3C5-1AFF863D948A Q37851992-3CCE2FCC-EB79-4E48-A707-CCD43D7E40DB Q37866784-71C36A9E-2076-44B2-9EED-3F4C700CD716 Q37892341-16E2CC85-6B95-4902-81CC-C7733A361BA3 Q38102613-5F00DC12-358B-4A20-BA58-C7671985E37F Q38189297-65A5EB96-54BB-4F28-B25A-434D604C7883 Q38376430-FD75EA60-3DD8-4E86-AFE3-298AEBB71D28 Q39044577-0BC66AE7-020F-4201-B61D-ECBB31CEBB03 Q39375125-6EE43290-4B16-48EF-99C5-6E22EB5611D4 Q40174767-229BD204-B522-47D4-967F-83B6904D8360 Q50882852-B1A76C95-F51F-4807-89CE-3E3B8351F6C6 Q52932452-48109C96-71DF-4715-9880-8DB51A887596 Q53085123-B4F0DF98-1594-4947-A5F3-CEF17E58AEC8 Q53734311-90E089CA-DBF0-4B02-AF14-12F92D69DE31 Q55023905-C0E03CDD-7493-4DE7-9060-B059103CC33C Q55260269-77BAF75A-AE0A-478A-88B5-612865DBD50E

P2860

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

http://www.wikidata.org/entity/Q34149992

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Twenty-five years of clinical ...... ng carcinoma in North America.

@ast

Twenty-five years of clinical ...... ng carcinoma in North America.

@en

Twenty-five years of clinical ...... ng carcinoma in North America.

@nl

type

label

Twenty-five years of clinical ...... ng carcinoma in North America.

@ast

Twenty-five years of clinical ...... ng carcinoma in North America.

@en

Twenty-five years of clinical ...... ng carcinoma in North America.

@nl

prefLabel

Twenty-five years of clinical ...... ng carcinoma in North America.

@ast

Twenty-five years of clinical ...... ng carcinoma in North America.

@en

Twenty-five years of clinical ...... ng carcinoma in North America.

@nl

P1433

Q34149992-E3EE44DE-0438-47B6-AF3E-2E6A90DB78E7

P1476

Q34149992-9AC6F7FD-8849-4C87-9597-3CF3CEE7BB32

P2093

Q34149992-27FD2DA5-E2E8-4388-8AF7-2B39E03CF1E7

Q34149992-4977AF74-A768-4E4D-B7F4-CFAA9F0717C9

Q34149992-527EFD3B-BDF2-46E5-96B8-79F1F5CF0D33

Q34149992-5350E429-5677-47C1-AF00-4C07CDB4D1E8

Q34149992-C7C9F692-C74D-4FD7-A9DB-39CB239F934E

P2860

Q34149992-0024D5B3-C30B-442D-838C-8617339A9134

Q34149992-01AFDB5F-B95F-4D56-83AD-D65CCA599493

Q34149992-08B1545F-6E55-4F7D-B25D-939CD823947B

Q34149992-0BA75814-557E-4811-9294-70653B6F0475

Q34149992-11F8EE84-B88D-463C-B00A-59DBA6555D9C

Q34149992-13C8E9E4-BF14-4592-9690-1D2DE6FA8B00

Q34149992-156A8C49-5EF1-423E-BDA7-3880FAA51C63

Q34149992-21EF74FF-D089-4C4A-B1AF-EA50CB90CC62

Q34149992-29F8B0FE-FBF5-4904-8022-B398487C6404

Q34149992-2A090DDB-EC66-421B-9D30-9604C20468BC

P304

Q34149992-16CC19F4-2877-4886-89B5-B37C54FB3603

P31

Q34149992-5AA60F72-E442-4962-9B95-49CA5A6527CB

P356

Q34149992-B0000755-0383-4E4A-B325-F0B0043EB750

P407

Q34149992-1F7FEF6A-0D57-41B9-B9DB-640216FBFCC0

P433

Q34149992-C73FB01B-49FB-46E2-9929-24EBE10DDC78

P478

Q34149992-E155226F-27B6-424A-B3C3-5E9490179105

P50

Q34149992-3E5933E2-B6DC-4D9F-B2EA-4CFA2632C21A

Q34149992-8637ABF9-CF33-40DE-9D87-13C73B7833D1

P577

Q34149992-1A8EC7F1-231A-4A8D-A4F0-3DBA611FF902

P5875

Q34149992-DB586293-8353-4892-BA50-7964893CAA38

P698

Q34149992-5161D494-4539-4074-852D-538001E7F5C7

P921

Q34149992-BA0E9F1F-6AA9-4A77-A342-A21B9F610763

P356

P1433

P1476

Twenty-five years of clinical ...... ng carcinoma in North America.

@en

P2093

Bruce E Johnson

http://www.w3.org/2001/XMLSchema#string

David H Johnson

http://www.w3.org/2001/XMLSchema#string

Frances A Shepherd

http://www.w3.org/2001/XMLSchema#string

Robert B Livingston

http://www.w3.org/2001/XMLSchema#string

Scott Saxman

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer.

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up.

Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma.

Assessment of the role of surgery for control of lung cancer.

Cigarette smoking and changes in the histopathology of lung cancer.

Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.

Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.

P304

1528-1538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.10841

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11152671

http://www.w3.org/2001/XMLSchema#string

P698

12237922

http://www.w3.org/2001/XMLSchema#string

P921